maureen trudeau

Head of medical oncology and hematology

Fred Hutch Cancer Center

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Medical Imaging Medical Imaging professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Maureen Trudeau is the Head of Medical Oncology and Hematology at the Odette Cancer Centre in Canada. Her research focuses on chemotherapy response prediction in breast cancer through advanced imaging techniques and machine learning. She has contributed significantly to the understanding of treatment strategies for early HER2-negative breast cancer, as well as the development of preference-based instruments for patient care. Dr. Trudeau's recent publications reflect her commitment to advancing clinical practices in oncology.

Articles (8)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Collaborators (4)

Michael Kolios

Professor

Ryerson University

CANADA

View details

Ali Sadeghi-Naini

Assistant Professor

York University

CANADA

View details

Andrea Eisen

McMaster University

CANADA

View details

Jawaid Younus

Associate Professor

Western University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

maureen trudeau

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging Study

Validation of Quantitative Ultrasound and Texture Derivative Analyses-Based Model for Upfront Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Prediction of Chemotherapy Response in Locally Advanced Breast Cancer Patients at Pre-Treatment Using CT Textural Features and Machine Learning: Comparison of Feature Selection Methods

Ribosomal RNA Degradation (RNA Disruption) in Tumour Cells: Mechanistic Insights and Potential Clinical Utility

The Omission of Anthracycline Chemotherapy in Women with Early HER2-Negative Breast Cancer—A Systematic Review and Meta-Analysis

A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer

A scoping review to create a framework for the steps in developing condition-specific preference-based instruments de novo or from an existing non-preference-based instrument: use of item response theory or Rasch analysis

Appraising Adjuvant Endocrine Therapy in Hormone Receptor Positive HER2-Negative Breast Cancer—A Literature Review

Collaborators (4)

Michael Kolios

Ali Sadeghi-Naini

Andrea Eisen

Jawaid Younus

Make your next move.